Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome

By Sales MF   Sóter MO   Candido AL   Fernandes AP   Oliveira FR   Ferreira ACS   Sousa MO   Ferreira CN   Gomes KB  

Gynecological Endocrinology, Vol. 29, Iss. 10, 2013-10 ,pp. : 936-939

Informa Healthcare

Access to resources Recommend Favorite

An Effect of the PAI-1 4G/5G Polymorphism on Cholesterol Levels May Explain Conflicting Associations with Myocardial Infarction and Stroke

By  

Cerebrovascular Diseases, Vol. 22, Iss. 2-3, 2006-07 ,pp. : 191-195

Karger

Access to resources Recommend Favorite

The 4G/5G-polymorphism in the PAI-1 gene is not associated with markers of atherosclerosis in male smokers

By Hoekstra T.   Geleijnse J.M.   de Waart F.   Nederhand R.   Kluft C.   Kok F.J.   Schouten E.G.  

Thrombosis Research, Vol. 107, Iss. 3, 2002-08 ,pp. : 115-119

Elsevier

Access to resources Recommend Favorite

PAI-I 4G/5G polymorphism and sudden cardiac death in patients with coronary artery disease

By Anvari A.   Schuster E.   Gottsauner-Wolf M.   Wojta J.   Huber K.  

Thrombosis Research, Vol. 103, Iss. 2, 2001-07 ,pp. : 103-107

Elsevier

Access to resources Recommend Favorite

The Role of the t-PA I/D and PAI-1 4G/5G Polymorphisms in African-American Adults With a Diagnosis of Myocardial Infarction or Venous Thromboembolism

By Hooper W.C.   Lally C.   Austin H.   Renshaw M.   Dilley A.   Wenger N.K.   Phillips D.J.   Whitsett C.   Rawlins P.   Evatt B.L.  

Thrombosis Research, Vol. 99, Iss. 3, 2000-06 ,pp. : 223-230

Elsevier

Access to resources Recommend Favorite